Meet Lee Smith

“We understand the challenges of developing new products in today’s biotech environment; appreciating both the daily technical hurdles that scientists have to deal with as well as fully understanding the challenges and pressures that senior management and CEOs face when facing stretch timelines to deliver a program on time, within budget while under pressure from the board of investors.”

GRA works with scientists and management in a variety of ways.  This might be helping in formulating the business strategy for a biotech business, assisting company boards, planning program timelines, through to dealing with complex scientific data, whether in CMC, preclinical or clinical areas.

GRA’s approaches and results have attracted a diverse array of clients working in the life sciences across multiple countries such as Takeda, Ipsen Biopharma, Mesoblast, Themis Bioscience, Abcam, Synairgen amongst others.  Our pragmatic and direct approach to solving problems has helped deliver positive results that have had dramatic long-term fiscal impact upon the business.  Today, GRA has become a trusted advisor to organisations across Europe, the United States and Asia.

GRA regularly contributes to industry journals and speak at international conferences freely sharing their experience and insights on improving biotech practices and businesses.